Iq Capital Partners Gp Iv A Llp investment portfolio

Pictura Bio creates a one‑minute pathogen detection platform (PIC‑ID) that uses single‑molecule fluorescent microscopy and machine‑learning image analysis to identify infectious agents from a single nasal or throat swab. The system is intended for point‑of‑care use in hospitals and clinics to deliver rapid, affordable diagnostics for respiratory viruses and other pathogens.

Risilience provides the Riise platform, a climate‑and‑nature risk analytics solution that quantifies physical and transition risks in financial terms. The service targets corporate finance, sustainability and risk teams, as well as financial‑services firms including banks, asset managers and private‑equity investors.